-
US close: S&P 500 and Nasdaq close at fresh record highs
10 Jul 2025 22:19 GMT
… ) $30.21 1.31%
Amgen Inc. (AMGN) $300.37 1.04%
Dow … . (ADBE) $371.43 -3.16%
Nasdaq 100 - Risers
American Airlines … . (SNPS) $566.19 2.48%
Nasdaq 100 - Fallers
Autodesk Inc … .15 -2.79%
NetEase Inc. Ads (NTES) $127.58 -2.65% …
-
Waldenstrom Macroglobulinemia Market Sees Surging Demand Across the 7MM Amid BTK Inhibitor Advancements | DelveInsight
14 Jul 2025 17:00 GMT
New York, USA, July 14, 2025 (GLOBE NEWSWIRE) -- Waldenstrom Macroglobulinemia Market Sees Surging Demand Across the 7MM Amid BTK Inhibitor Advancements | DelveInsight The Waldenstrom macroglobulinemia market is witnessing steady growth driven by advances …
-
From Magic Bullets to Medical Insights: How RFK Jr.’s Critique Shapes the Future of Pharma Advertising
03 Jul 2025 18:05 GMT
… implications as claims, preventing the ad from ever being aired. Interestingly … ads versus in-depth journalism, particularly in healthcare.
While 60-second advertisements … for major clients such as Amgen Oncology, IBM Watson, and Foundation …
-
Amgen and Zai Lab’s trial of gastric cancer therapy meets primary endpoint
01 Jul 2025 10:12 GMT
Amgen and Zai Lab have … gastric and gastroesophageal junction adenocarcinoma.
Advertisement
Advertisement
In addition to FORTITUDE-101 … second half of 2025.
Amgen research and development executive vice … gastric cancer."
"Amgen and Zai Lab’s trial …
-
REZOLVE-AD and Rezpegaldesleukin for Atopic Dermatitis, with Jonathan Silverberg, MD, PhD, MPH
28 Jun 2025 00:38 GMT
… its ongoing phase 2b REZOLVE-AD trial, highlighting the efficacy … Body Surface Area improvement,
vIGA-AD 0/1 (clear … patients with vIGA-AD 3 and vIGA-AD 4.
Pharmacodynamic data … Silverberg include AbbVie, lamar, Aldena, Amgen, AObiome, Arcutis, Arena, Asana, …
-
Kennedy has Big Pharma ads in his sights — and he's not the only one mulling a crackdown
18 Jun 2025 12:50 GMT
… -to-consumer pharmaceutical ad guidelines.
" … to-consumer pharmaceutical advertising must prioritize accuracy, … advertising and promotions in 2023 among the drugmakers AbbVie, Amgen … "Restricting pharmaceutical ads would have serious consequences …
-
Amgen Inc. (NASDAQ:AMGN) Q1 2025 Earnings Call Transcript
02 May 2025 13:09 GMT
… &A Session
Follow Amgen Inc (NASDAQ:AMGN) Follow Amgen Inc (NASDAQ:AMGN) We may use … invested in direct-to-consumer advertising now, and we expect a … 2025 Earnings Call.
Follow Amgen Inc (NASDAQ:AMGN) Follow Amgen Inc (NASDAQ:AMGN) We may use …
-
2025 TITAN Brand Awards Celebrates Global Leaders in Branding and Advertising Excellence for Season 1 Competition
03 Jun 2025 14:00 GMT
… connection through branding and advertising.
In this latest … including notable names such as Amgen, REQ, Indeed, Rocket, … winners in branding and advertising excellence, visit https:… excellence in branding and advertising across various industries …
-
Amgen CEO Robert A. Bradway to Receive Honorary Degree from KGI
08 May 2025 15:00 GMT
Claremont, CA, May 08, 2025 (GLOBE NEWSWIRE) -- During the Keck Graduate Institute commencement ceremony on May 17, 2025, Robert A. Bradway will receive an honorary Doctor of Philosophy in Applied Life Sciences degree in recognition of his significant …
-
PhRMA Uses Advocacy Groups, Advertising to Turn PBMs Into the Villains in the War Over Drug Prices
05 May 2025 22:27 GMT
… ), manufacturers like Pfizer, Eli Lilly, Amgen, and AstraZeneca are seeking to … donations to political groups and ads, many of which blamed benefit … citizens. PhRMA also bought targeted ads in legacy and social media …
About
© 1995-2025